So much distrustAs my favorite poster once said '' quit whining and sell and move on"
I think he should follow his own advice
The problem here for some is the is lack of experience in how clinical trials are conducted....I have learned the hard way to only bet money I dont need on clinical trials be they Phase 1 .phase 2 or even Phase 3,...Cancers are the hardest to treat ilnesses especially for advanced patients....Miracle cures are not run of the mill ....Those who have fantasized about fantastic results in Phase 1a have set themselves up for disappointment....Those who thought the purchase of Katana 3 years ago was akin to buying a Lottery Ticket (which it was) are pleased with where we stand now in Oncology...
I am disapointed with the F8 formulation being on hold 9not the company s fault) and the corresponding hold on Nash........I am still a believer inTesamorelin .....Paul did not elaborate today on the reasons that Egrifta is gaining traction but I think HIV doctors are starting to prescribe Egrifta to their Lipo patients as a prevention for Nash ALL legal and according to the multitude of studies posted by Scarlett prescribing Tesamorelin is a win win situation for Lipo patients
I read the transcripts of the CC and I still think that financing is a big challenge ......time will tell